Flamel Technologies SA (FLML) was a big mover last session, as its shares rose almost 9% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 17% in the past one-month time frame.
In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Flamel Technologies currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked medical stocks include Lannett Company, Inc. (LCI), Jazz Pharmaceuticals Plc (JAZZ) and Grifols, S.A. (GRFS). All three companies carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
FLAMEL TECHNOLOGIES ADS (FLML): Free Stock Analysis Report
LANNETT COMP (LCI): Free Stock Analysis Report
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
GRIFOLS SA ADS (GRFS): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading